SCM
Stonepine Capital Management Portfolio holdings
AUM
$102M
1-Year Return
40.04%
This Quarter Return
+131.02%
1 Year Return
+40.04%
3 Year Return
+160.28%
5 Year Return
+195.28%
10 Year Return
–
AUM
$143M
AUM Growth
+$40.4M
(+39%)
Cap. Flow
+$1.99M
Cap. Flow
% of AUM
1.39%
Top 10 Holdings %
Top 10 Hldgs %
81.78%
Holding
32
New
6
Increased
11
Reduced
6
Closed
9
Top Buys
| 1 |
AFMD
Affimed
AFMD
|
$10.8M |
| 2 |
AMRN
Amarin Corp
AMRN
|
$6.68M |
| 3 |
ADMS
Adamas Pharmaceuticals, Inc.
ADMS
|
$5.65M |
| 4 |
Evolus
EOLS
|
$4.81M |
| 5 |
Gyre Therapeutics
GYRE
|
$2.09M |
Top Sells
| 1 |
BDSI
BioDelivery Sciences International, Inc.
BDSI
|
$10.9M |
| 2 |
Enanta Pharmaceuticals
ENTA
|
$7.8M |
| 3 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$7.09M |
| 4 |
Ligand Pharmaceuticals
LGND
|
$2.98M |
| 5 |
ALIM
Alimera Sciences, Inc.
ALIM
|
$1.55M |
Sector Composition
| 1 | Healthcare | 92.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
KalVista Pharmaceuticals
KALV
$796M
| – | – |
-33,033
| Closed | -$383K |
|
|
27
Ligand Pharmaceuticals
LGND
$3.25B
| – | – |
-48,034
| Closed | -$2.98M |
|
28
Travere Therapeutics
TVTX
$1.93B
| – | – |
-29,675
| Closed | -$344K |
|
|
ALIM
29
DELISTED
Alimera Sciences, Inc.
ALIM
| – | – |
-182,694
| Closed | -$1.55M |
|
|
CORV
30
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
| – | – |
-509,356
| Closed | -$1.02M |
|
|
BDSI
31
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| – | – |
-2,595,855
| Closed | -$10.9M |
|